Synchron raises $200 million to power non-surgical brain interface commercialization
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Marks first international filing for Evofem’s single-dose oral treatment
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase III IMforte study
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Subscribe To Our Newsletter & Stay Updated